Cen, Steven
Gebregziabher, Mulugeta
Moazami, Saeed
Azevedo, Christina J.
Pelletier, Daniel
Funding for this research was provided by:
National Multiple Sclerosis Society (RG-1802-30140)
NIH (R01NS062885)
Article History
Received: 18 April 2023
Accepted: 26 September 2023
First Online: 28 September 2023
Change Date: 15 December 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-47966-0
Competing interests
: In the past 3 years, Dr. Azevedo has received grant support from the National Multiple Sclerosis Society and the NIH. She has received consulting fees from Horizon Therapeutics, Genentech, Sanofi Genzyme, TG Therapeutics, and EMD Serono. She has received honoraria for serving on grant review committees for the Department of Defense and the NIH and for participation in unbranded CME activities from the American Academy of Neurology, Efficient LLC, Spire Learning, and Catamount Medical Education. Dr. Cen, Dr. Pelletier, Dr. Gebregziabher and Mr. Moazami have no competing interests.